{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:29:15Z","timestamp":1775190555045,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:00:00Z","timestamp":1598140800000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.04.090","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T17:32:24Z","timestamp":1557250344000},"page":"5724-5730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005\u20132016"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-6273","authenticated-orcid":false,"given":"Jackie","family":"Kleynhans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-2302","authenticated-orcid":false,"given":"Cheryl","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-4033","authenticated-orcid":false,"given":"Meredith","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-347X","authenticated-orcid":false,"given":"Stefano","family":"Tempia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny","family":"Crowther-Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"de Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"von Gottberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.04.090_b0005","doi-asserted-by":"crossref","first-page":"e0149104","DOI":"10.1371\/journal.pone.0149104","article-title":"HIV infection and the epidemiology of invasive pneumococcal disease (IPD) in South African adults and older children prior to the introduction of a pneumococcal conjugate vaccine (PCV)","volume":"11","author":"Meiring","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.04.090_b0010","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1016\/j.vaccine.2013.04.077","article-title":"Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003\u20132008","volume":"31","author":"von Gottberg","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.090_b0015","series-title":"Vaccine information for parents and caregivers","author":"National Institute for Communicable Diseases","year":"2016"},{"key":"10.1016\/j.vaccine.2019.04.090_b0020","unstructured":"World Health Organization. WHO-UNICEF estimates of PCV3 coverage. 2017."},{"key":"10.1016\/j.vaccine.2019.04.090_b0025","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","article-title":"Effects of vaccination on invasive pneumococcal disease in South Africa","volume":"371","author":"von Gottberg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.04.090_b0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/heapol\/czp057","article-title":"The National Strategic Plan of South Africa: what are the prospects of success after the repeated failure of previous AIDS policy?","volume":"25","author":"Wouters","year":"2010","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vaccine.2019.04.090_b0035","unstructured":"World Health Organization. Resistant pneumococcal infections. 2001. ISBN WHO\/CDS\/CSR\/DRS\/2001.6 Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/66846. Last accessed: 27 June 2018"},{"key":"10.1016\/j.vaccine.2019.04.090_b0040","first-page":"493","article-title":"Pediatric bacterial meningitis surveillance \u2013 African region, 2002\u20132008","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.04.090_b0045","first-page":"1159","article-title":"Global invasive bacterial vaccine-preventable diseases surveillance\u20132008-2014","volume":"63","author":"Murray","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.04.090_b0050","first-page":"579","article-title":"Part V. Surveillance activities","volume":"101","author":"Bamford","year":"2011","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2019.04.090_b0055","series-title":"2015 Annual report","author":"GERMS-SA","year":"2015"},{"key":"10.1016\/j.vaccine.2019.04.090_b0060","unstructured":"Econex. The South African Private Healthcare Sector: role and contribution to the economy. 2013. Available from: http:\/\/www.mm3admin.co.za\/documents\/docmanager\/f447b607-3c8f-4eb7-8da4-11bca747079f\/00060290.pdf. Last accessed: 4 May 2017."},{"key":"10.1016\/j.vaccine.2019.04.090_b0065","unstructured":"Statistics South Africa. Statistical release P0302 \u2013 Mid-year population estimates 2016. 2016. Available from: http:\/\/www.statssa.gov.za\/publications\/P0302\/P03022016.pdf. Last accessed: 15 July 2017."},{"key":"10.1016\/j.vaccine.2019.04.090_b0070","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper-2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.090_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0755-7","article-title":"Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis","volume":"14","author":"Alari","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2019.04.090_b0085","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.vaccine.2016.07.038","article-title":"Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD","volume":"34","author":"Ben-Shimol","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19305900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:04Z","timestamp":1759401304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19305900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":16,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19305900"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005\u20132016","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}